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SUMMARY
The current mainstay for control of the four major helminth diseases in humans (lymphatic ﬁlariasis, onchocerciasis, soil-
transmitted helminthiases and schistosomiasis) is with preventive chemotherapy by mass administration of key anthel-
minthics. Following the London Declaration on Neglected Tropical Diseases in 2012, a roadmap for the elimination
and control of these helminthiases by 2020 has been devised. With expected declines in prevalence and intensity of
these infections, there is urgent need for implementing more sensitive, high-throughput and cost-eﬀective diagnostic
tools. Currently available diagnostic approaches for surveying, monitoring and evaluating helminth control programmes
are based on microscopical observation of eggs/larvae, and/or detection of antibodies or parasite antigens in stool, urine or
blood; all relatively low-throughput and of limited sensitivity and speciﬁcity. Newly proposed approaches for helminthiases
diagnosis include thenucleic acid-basedmethods of (multiplex) real-timepolymerase chain reaction assays, loop-mediated iso-
thermal ampliﬁcation and recombinase polymerase ampliﬁcation. However, as well as sensitivity/speciﬁcity evaluation, their
comparison to current ‘gold standard’ diagnostics and future application in individual-/community-based diagnosis, or in
xenomonitoring requires consideration of relative costs, agreement of standardmethods and strategic interpretation of result-
ingdatabefore control/eliminationprogrammesmightbestutilizemoleculardiagnostics to informdecisionmaking.Wereview
current nucleic-acid-based molecular diagnostic methods and highlight the needs and future research required to reﬁne these
tools for monitoring and evaluation of control and elimination programmes for four major human helminthiases.
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INTRODUCTION
Lymphatic ﬁlariasis (LF), onchocerciasis, soil-
transmitted helminthiases (STHs) and schistosom-
iasis are four major helminth diseases in humans
targeted for control with preventive chemotherapy
(PC) by mass drug administration (MDA). Follow-
ing the London Declaration on Neglected Tropical
Diseases (NTDs) in 2012, the World Health
Organization (WHO) developed a roadmap to pri-
oritize and guide the scaling-up of interventions
for control and elimination of NTDs by 2020
(World Health Organization, 2015). Current goals
include elimination of LF and control of onchocer-
ciasis, soil-transmitted helminths and schistosomia-
sis by sustaining, expanding and extending MDA
alongside condition-speciﬁc interventions including
vector control and water, sanitation and hygiene
measures to abate transmission.
Access to and deployment of appropriate diagnos-
tic tools is crucial within disease control and elimin-
ation programmes throughout their inherent four
key time points: (i) initial mapping to establish
disease prevalence, (ii) monitoring the impact of
interventions after they are started, (iii) deciding
when to stop interventions and (iv) post-elimination
surveillance (Solomon et al. 2012). Diagnostic tools
which are both highly sensitive and cost-eﬀective,
particularly when scaling-up MDA and control
interventions and within ‘endgame’ ﬁnal stages of
elimination scenarios and post-MDA surveillance,
are key to the impact and success of control and elim-
ination programmes (McCarthy et al. 2012). The
expected reduction in both infection prevalence
and intensity in communities will result in the
need to detect very low levels of infection and
screen larger numbers of people or vectors, often
returning a much greater number of negative tests
to provide conﬁdence in excluding presence of infec-
tions. The reliability of diagnostics under such scen-
arios is vital when the decision to stop MDA in an
area has to be made, as well as in the post-MDA
monitoring stages: residual low levels of infection,
if overlooked, can cause resurgence of transmission
and subsequent endemic infection. More sensitive
diagnostics can also aid in the early detection of
drug resistance potentially emerging in parasite
populations as a result of increased exposure to
drugs due to scaling-up of MDA. Additionally,
given the nature of integrated MDA, further
unique challenges exist in devising strategies,
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protocols and tests for each disease in parallel when
appropriate.
Currently, for MDA-targeted helminths the prag-
matic ‘gold standards’ for human diagnosis as
endorsed by the WHO for implementation in re-
source-poor settings include the microscopic iden-
tiﬁcation of parasite larvae in blood (LF) or skin
snips (onchocerciasis), eggs or larvae in stools or
urine (STHs and schistosomiasis) or the detection
of antibodies or worm antigens circulating in blood
(LF, onchocerciasis and schistosomiasis) or urine
(schistosomiasis) (McCarthy et al. 2012). All these
‘gold standard’ tools, although appropriate for
mapping disease in moderate-to-high intensity and
prevalence areas, show their limitations for impact
monitoring and post-elimination stages: in particu-
lar for the latter stage, it is proposed that the ideal
test format would be a high-throughput laboratory
assay (Solomon et al. 2012).
Research requirements to advance current diag-
nostic tools for human helminthiases in the context
of control and elimination programmes have been
extensively reviewed (McCarthy et al. 2012; World
Health Organization, 2012). However, there remains
lack of funding commitment despite recognition of
the fundamental role of diagnostics in meeting the
2020 goals for NTDs (Hotez et al. 2016). With more
countries scaling up MDA and associated interven-
tions and approaching elimination of at least some of
these infections, an important question is whether
eﬀorts shouldbe focusedondevelopingnovel sensitive
diagnostics for resource-poor and/or ﬁeld settings, or
validating throughput, cost-eﬀectiveness andbuilding
required capacity in implementing existing tools.
Future solutions to the need for more sensitive,
high-throughput diagnostics could include develop-
ment of antibody, antigen and nucleic acid detec-
tion-based methods as all these approaches could
lend themselves to levels of automation, handling
of larger sample numbers, and sensitivity that hel-
minth elimination programmes will need. These
approaches, however, would require investment in
capacity building with equipment, training and
general resources as well as the necessary initial re-
search to develop, validate, standardize and quality
assure assays. Whilst antibody and antigen detection
assays are of great potential value and most certainly
warrant further investment, it is the nucleic-acid-
based methods that arguably may currently oﬀer the
most rapid route to multiplexing and implementation
within helminth control and eliminationprogrammes.
Furthermore, nucleic-acid-based methods may also
oﬀer ancillary beneﬁt through their potential to
monitor population genetic variations in helminths
through possible drug pressure selection changes and
thus inform strategies for judicious use of the few
eﬃcacious anthelmintics upon which we rely heavily.
Proposed nucleic-acid-based molecular approaches
as candidates for sensitive, high-throughput
diagnostics, include (multiplex) real-time quantitative
polymerase chain reaction (qPCR) assays or isother-
mal ampliﬁcation methods, such as loop-mediated
isothermal ampliﬁcation (LAMP), nucleic acid
sequence-based ampliﬁcation (NASBA) and recom-
binase polymerase ampliﬁcation (RPA). However, al-
though these molecular methods do oﬀer the required
sensitivity and high-throughput, their acceptance and
uptake ishamperedby threemain ‘obstacles’, thatmay
be categorized as; ‘Cost’, through the expense
of equipment, reagents and training; ‘Standard
Method’, in terms of there being as yet no agreement
on a speciﬁc ‘best approach/method and quality stan-
dards’; and ‘Result Interpretation’ with regard to how
control/elimination programmes might best use mo-
lecular data to inform decision making (summarized
in Table 1).
PCR is one of the most promising approaches to
detect parasite DNA or RNA in human or vector
samples due to its higher diagnostic sensitivity and
speciﬁcity compared to microscopy or immunodiag-
nostics through antibody or antigen detection. In
particular real-time qPCR has become the mainstay
of molecular diagnostics in many clinical microbiol-
ogy laboratories across the world for detecting
bacteria, viruses, fungi and parasites in clinical
samples (Espy et al. 2006; Verweij and Stensvold,
2014), with a comprehensive number of published
qPCR assays for pathogen detection.
However, operational issues such as the high cost
of the instrumentation required for thermal cycling
and signal detection and the need for well-equipped
laboratories, have so far hindered use of qPCR in re-
source-poor settings. In the past few years, isother-
mal methods allowing the ampliﬁcation of nucleic
acids at constant temperature and with minimal
equipment have been described and presented as
more ‘ﬁeld-friendly’ and cost-eﬀective alternatives
to qPCR, particularly for their potential use as
point-of-care tests (Craw and Balachandran, 2012).
Amongst these methods, the LAMP (Notomi et al.
2000) is the most researched and characterized for
parasite diagnostics. For example, a variety of
LAMP assays have been published for the detection
of malaria (Han, 2013) and trypanosomes
(Deborggraeve and Büscher, 2012). Another isother-
mal ampliﬁcation technique, known as NASBA is a
method, which ampliﬁes RNA templates, mimick-
ing the retroviral replication mechanism, and is par-
ticularly suited for the diagnosis of RNA viruses and
in detecting viable targets (Craw and Balachandran,
2012). Although NASBA has been successfully
applied to the diagnosis of parasitic infections such
as leishmaniasis (de Ruiter et al. 2014) and trypano-
somiasis (Mugasa et al. 2014), it has yet to be applied
to human helminths. More recently a further iso-
thermal method, the RPA (Piepenburg et al.
2006) has come to the attention of the scientiﬁc com-
munity. In RPA, target ampliﬁcation is rapidly
2Corrado Minetti and others
http:/www.cambridge.org/core/terms. http://dx.doi.org/10.1017/pao.2016.13
Downloaded from http:/www.cambridge.org/core. Liverpool School Of Tropical Medicen, on 25 Nov 2016 at 14:11:45, subject to the Cambridge Core terms of use, available at
accomplished (20–40 min) using a combination of
target-speciﬁc primers and a recombinase enzyme
(which form a recombinase ﬁlament inserting the
primers when the speciﬁc target is encountered via
a strand exchange mechanism) and single-strand
DNA-binding proteins, which stabilizes and pre-
vents re-annealing of the DNA double-strand
(Craw and Balachandran, 2012). The RPA approach
has been applied for the detection of a variety of viral
pathogens, including Ebola (Faye et al. 2015) and
also of urinary schistosomiasis (Rosser et al. 2015).
With increasing focus towards in-country laboratory
capacity building and the necessity for integrating
interventions and monitoring activities for diﬀerent
Table 1. Current obstacles, potential solutions and research priorities for the large-scale implementation of
molecular diagnostics in MDA-targeted helminths control and elimination programmes
Obstacle Potential solutions Research priorities
‘Cost’ of molecular diagnostics is
prohibitive for current helminth
NTDs programmes
Reduce sample collection and process-
ing costs by using existing NTDs
diagnostic pathways as a source for
suitable human and vector samples
• Foster a greater collaboration across
groups working on diﬀerent diseases
• Optimize sample collection, storage
and extraction methods for helminth
NTDs screening
Reduce the cost and increase the
throughput capacity of molecular
screening by devising strategies for
pooling samples (increasing sample
size) and detecting multiple pathogens
from the same samples
• Optimize sample pooling methods
(alongside extraction and ampliﬁca-
tion) to increase sample size without
sacriﬁcing sensitivity of detection
• Further development of multiplex
assays
Increase the investments from key sta-
keholders to support post-MDA sur-
veillance implementation of molecular
diagnostics
• Modelling the costs of programme
failure compared with the costs of
surveillance programme
• Modelling the actual costs of mo-
lecular diagnostics compared with the
‘gold standards’, including factors
such as sample volumes, frequency of
sampling and equipment, supplies,
personnel and training costs
‘Standard Method’ – No clear con-
sensus on which molecular diagnostic
platform(s) would best serve the needs
of control and elimination
programmes
Ensure the platform that is most ap-
propriate for a particular setting and
that responds to the needs and cap-
abilities of control programmes is used,
to balance costs and diagnostic
eﬀectiveness
• Complete costing and thorough
comparison of the available molecular
diagnostic platforms as applied to
diﬀerent helminth diseases and
scenarios
• Identify (with inputs from key sta-
keholders) new molecular diagnostic
platforms and approaches to address
the changing needs of control and
elimination programmes
Use of standard quality assessment
schemes and of quantiﬁed reference
materials to ensure robust and com-
parable standards between pro-
grammes and countries
• Establishment of globally agreed
standard quality assessment schemes
and of a central a resource of quan-
tiﬁed reference materials
Promote non-invasive sampling strat-
egies to maintain community support
and to simplify sampling logistics
• Further development of molecular
diagnostic assays using non-conven-
tional biological samples (urine,
saliva, insect excreta)
‘Result Interpretation’ – Little or no
guidance on how to use and interpret
molecular diagnostics to conﬁrm re-
sidual transmission and/or local
elimination
Develop suitable guidelines for the
determination of the level of infection
intensity (rather than prevalence)
needed for sustained transmission
• Evaluation of the potential for mo-
lecular diagnostic assays to precisely
quantify the worm burden in the
human host and vectors, also as
indicators of morbidity
Develop a focal sampling strategy
aimed towards reservoirs of infection
• Develop risk maps (including factors
such as human and vector behaviour)
which can be used to direct sampling
for molecular diagnostics
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NTDs, molecular diagnostic methods are now suit-
able to explore in terms of value and eﬀectiveness in
helminth control and elimination programmes.
AIMS OF THE REVIEW
The aims of this review are threefold. First, to
compare the features of qPCR and the two isother-
mal tools for DNA ampliﬁcation (LAMP and
RPA) for which examples in human helminths
exist, and so are relevant for their potential use in
control and elimination programmes of the four
major human helminthiases. Second, to review the
qPCR, LAMP and RPA assays currently available
for patient and/or community diagnosis or xenomo-
nitoring of LF, onchocerciasis, STHs and schisto-
somiasis. Third, to identify the research needs and
implementation issues which should be considered
for the large-scale adoption of such molecular diag-
nostic tools to assist the control and elimination pro-
grammes, particularly during the post-MDA
surveillance stages.
WHAT FEATURES REALLY MATTER: qPCR VS
LAMP VS RPA
When comparing the features of diﬀerent molecular
detection formats or assays, it is important to con-
sider the characteristics most relevant to the
purpose for which the tools are meant to be used.
Analytical or diagnostic sensitivity and speciﬁcity
are inﬂuenced by how the assay is designed and opti-
mized and how samples are processed before testing
(Verweij and Stensvold, 2014). For example, choos-
ing a molecular target with multi-copy genes and
using an appropriate method to extract nucleic
acids eﬃciently (in terms of both yield and purity)
from samples will allow higher sensitivity of detec-
tion. Following careful design and extensive testing
of extraction methods and reaction set up, similar
and very low analytical sensitivities can be accom-
plished using either qPCR or isothermal assays
(Han, 2013). However, the lack of standardization
in protocols between laboratories and published
papers makes a direct comparison of assays based on
the above characteristics diﬃcult: variability
between laboratories is commonly observed in terms
of sample volumes, storage conditions and extraction
methods (de Ruiter et al. 2014). Also, when compar-
ing the sensitivity of detection between a newmolecu-
lar assay and one that is already available, the choice of
the comparison assay is crucial. For example, the sen-
sitivity of LAMP assays is commonly reported
against a PCR performed using the same two
primers employed in the LAMP reaction. In
general and whenever possible, comparison should
be made against the most sensitive assay available.
Cost-eﬀectiveness and scalability of molecular
diagnostics will depend on equipment and reaction
costs, throughput capacity and the ability for tests
to be multiplexed to amplify multiple targets from
the same sample. It will be crucial to optimize
these features for use in control and elimination cam-
paigns of MDA-targeted helminths. A general com-
parison of qPCR, LAMP and RPA based on some of
these features is shown in Table 2.
Cost of reagents and equipment and the issue of target
quantiﬁcation
Real-time qPCR has a high cost associated with
reagents and equipment needed for thermal cycling
and signal detection, although the cost can vary
between models and according to the machine multi-
plex capacity. During qPCR the ampliﬁed target de-
tection happens ‘real-time’ using ﬂuorescent
intercalating dyes binding to the nucleic acids
(such as SYBR-Green) or ﬂuorescence-labelled
probes (such as TaqMan probes) (Verweij and
Stensvold, 2014): this feature makes the detection
of ampliﬁcation quantitative, allowing the determin-
ation of the pathogen load in samples. Quantifying
parasite load is a key aspect in the diagnostics of hel-
minths and assessment of morbidity and control,
where determining infection intensity is more im-
portant than calculating prevalence (McCarthy
et al. 2012).
Isothermal methods can amplify nucleic acids at a
constant (and relatively lower, if compared with
qPCR) temperature using a simple water bath or
heat block: in the case of RPA, successful ampliﬁca-
tion using simply the body heat of the operator has
been proven possible (Crannell et al. 2014). A wide
range of approaches are available for the qualitative
detection of LAMP and RPA products, including
gel electrophoresis, in-tube ﬂuorescence, lateral
ﬂow detection with immunochromatographic strips
(Craw and Balachandran, 2012) and also by naked
eye using pH-sensitive dyes (Tanner et al. 2015).
The ability to perform nucleic acid ampliﬁcation in
the absence of expensive instrumentation, under
ﬁeld conditions in resource-poor setting, has been
the major selling point for LAMP and similar
methods as a ‘new generation’ of molecular diagnos-
tic tools. However, if quantiﬁcation of the target is
needed, the advantage of isothermal methods over
qPCR in terms of equipment requirements vanishes
since detection must be accomplished by turbidi-
metric or ﬂuorometric approaches requiring similar
or identical equipment to qPCR (Zhang et al. 2014).
One or more than one pathogen(s)? The issue of
multiplexing
Another important consideration to be made when
estimating the cost per reaction for each platform is
whether the aim is to detect one (singleplex) or
more than one (multiplex) targets (parasite species
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Table 2. Qualitative comparison of qPCR, LAMP and RPA based on features relevant to implementation of molecular diagnostics for MDA-targeted helminths
control and elimination
Method
Equipment cost
QL & QT
Cost/reaction
SX & MXa
Throughput
capacity
Multiplexing
capacity
Target
quantiﬁcation
Sensitivity to
inhibitors
Genotyping
capacity Essential references
qPCR − & − (±) & + + + + (±) + (Espy et al. 2006; Verweij and
Stensvold, 2014)
LAMP − & + + & unknown − (±) (±) + (±) (Notomi et al. 2000; Zhang et al.
2014; Craw and Balachandran,
2012)
RPA − & + − & unknown − (±) (±) + (±) (Piepenburg et al. 2006; Craw and
Balachandran, 2012)
The ‘positive’/‘negative’ symbols (‘+’, ‘±’, ‘−’) indicate qualitatively assigned comparative suitability, performance, beneﬁt and/or advantage of methods for the indicated features as
follows: ‘+’ indicates relative comparable superior suitability performance, increased beneﬁt and/or advantage; ‘(±)’ indicates relative comparable/no diﬀerence in suitability, perform-
ance, similar beneﬁt and/or equitable vantage; ‘−’ indicates relative comparable inferior suitability, performance, reduced beneﬁt and/or disadvantage.
a Excluding sample collection, extraction, consumables and primers costs: qPCR SX $0.55 (intercalating dye detection) – $0.81 (probe detection), MX (two targets, probe detection)
$0.87 (Source: http://blog.biosearchtech.com/how-much-is-your-qpcr-assay-really-costing-you); LAMP SX $0.26 (estimated using the Bst 2·0 DNA polymerase kit from New
England Biolabs: $264 for 1 mL of 8000 units mL−1 of enzyme for 1000 reactions at 1 µL of enzyme in 25 µL total reaction volume per manufacturer’s standard protocol); RPA
SX $4.27 (estimated using the TwistAmp® Basic kit from TwistDX: $410 for 96 reactions). qPCR, quantitative (real-time) polymerase chain reaction; LAMP, loop-mediated iso-
thermal ampliﬁcation; RPA, recombinase polymerase ampliﬁcation; QL, qualitative detection; QT, quantitative detection; SX, singleplex reaction (one target); MX, multiplex reac-
tion (more than one target); mL, millilitre; μL, microlitre; $, US dollar
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in this case) simultaneously. Currently, RPA has the
highest cost per sample and LAMP the lowest for a
single target reaction (Table 2). The cost-eﬀective-
ness of qPCR at less than a dollar for a singleplex re-
action increases as more targets are ampliﬁed and
detected in the same tube: recent estimates showed
that the cost per reaction tube increases only slight-
ly from a single target ($ 0·82) up to, for example,
four targets ampliﬁed ($ 1·01). As a consequence,
the multiplexing capacity of qPCR implies a signiﬁ-
cant decrease in the hands-on time and increase in
throughput capacity. The upper limit of targets that
can be ampliﬁed in a multiplex qPCR assay using,
for example, TaqMan probes depends on the
number of diﬀerent dyes the machine is able to
detect, but using microﬂuidic technologies such as
TaqManArray Cards (TACs) can allow the detection
of up to 19 diﬀerent targets (Liu et al. 2013).Whether
the samemultiplexingdynamics can in timebe applied
to the isothermal tools remain tobe seen.Although the
possibility of amplifying multiple targets has been
shown in both LAMP (Aonuma et al. 2010; Zhang
et al. 2014) and RPA (Crannell et al. 2016), both the
multiplexing and sample throughput capacity of
these approaches are still reduced if compared with
qPCR and are not well established at present.
Parasite genotyping: an added value
The possibility of obtaining additional information
on genetic makeup of parasites alongside detection
should be considered an added value too. For
example, molecular diagnostics can be applied to
the detection of single nucleotide polymorphisms
(SNPs) in the beta-tubulin gene sequence, which
has been shown to be associated with resistance to
benzimidazole drugs in a variety of animal nematode
parasites (Kotze et al. 2014), and potentially STHs
(Diawara et al. 2013) and Wuchereria bancrofti
(Schwab et al. 2005). The detection of SNPs by
qPCR using TaqMan probes is well established
(Espy et al. 2006), whereas it is still in its infancy
for isothermal tools such as LAMP and RPA
(Craw and Balachandran, 2012). Where and when
drug resistance genes and alleles are known, inclu-
sion of such molecular tests within standard diagnos-
tic monitoring surveys could ensure early detection
of emergence of potential drug resistance and thus
inform appropriate responsible strategies in judi-
cious use of existing precious drugs on which
MDA programmes rely signiﬁcantly.
Are we really considering all costs?
It is important to stress that the real cost-eﬀective-
ness of molecular diagnostics must also include
costs, which are usually overlooked, such as those
associated with sample collection, storage and ex-
traction. Particularly in relation to assay sensitivity
and throughput capacity, the extraction of DNA
and/or RNA from the samples is a crucial step
(Verweij and Stensvold, 2014). Depending on the
nature and number of samples processed, extractions
can be expensive and time-consuming. The possibil-
ity of running molecular assays using unprocessed or
minimally processed samples is highly attractive in
terms of reducing the cost and time of extractions.
It is a common belief that isothermal methods are
more robust than PCR-based methods are to
ampliﬁcation inhibition due to sample contami-
nants, as shown in publications reporting pathogen
detection by RPA directly from urine (Krõlov
et al. 2014) or by LAMP from crude or boiled
insects (Alhassan et al. 2014; Nzelu et al. 2014) or
freshwater samples (Koloren et al. 2011). Although
these results are promising, the eﬀect of ampliﬁca-
tion inhibition on qPCR, LAMP and RPA must
be thoroughly tested in diﬀerent samples to avoid
compromising the sensitivity of detection in
seeking to reduce extraction costs.
OVERVIEW OF AVAILABLE qPCR, LAMP AND RPA
ASSAYS FOR EACH HELMINTHIASIS
The major qPCR, LAMP and RPA assays described
for the human diagnosis and xenomonitoring of LF,
onchocerciasis, STHs and schistosomiasis are sum-
marized in Table 3.
Lymphatic ﬁlariasis
PCR detection of the causative agents of LFW. ban-
crofti andBrugia malayi in blood samples or mosqui-
toes has been widely explored through a variety of
formats and gene targets (Alhassan et al. 2015).
Real-time PCR assays have been developed using
highly repeated sequences in parasites’ genomes,
namely SspI (Lulitanond et al. 2004) and LDR
(Rao et al. 2006a) in W. bancrofti and HhaI (Rao
et al. 2006b) in Brugia. The W. bancrofti LDR
qPCR has been successfully used to amplifyW. ban-
crofti DNA from dried nucleopore membranes
stored from 6 months up to 4 years, as well as from
dried blood on ICT sample application pads and in-
dividual mosquitoes (Rao et al. 2006a). The same
assay later allowed a quantiﬁcation of microﬁlarial
load from dried blood spots, and proved to be suit-
able for screening pooled blood spots with a detec-
tion limit of one positive spot detected in a pool of
12 negative aliquots (Plichart and Lemoine, 2013).
The detection of B. malayi in blood by qPCR has
also been successfully achieved (Rao et al. 2006b).
In this study, 17 out of 31 (54·8%) amicroﬁlaremic
blood samples collected during the day tested posi-
tive by PCR. A PCR-positivity rate in day-collected
blood samples similar to night-collected samples has
been also observed in areas with nocturnally periodic
W. bancrofti (Lucena et al. 1998).
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Table 3. Overview of qPCR, LAMP and RPA assays published for diagnosis and xenomonitoring of the MDA-targeted helminths
Parasite species Assay type Target gene(s) Sample type(s)
Detection limit
(comparison assay)
Performance on clinical or ﬁeld
samples (comparison assays, if
any) [gold standard test, if any] Reference(s)
Filarial worms
W. bancrofti qPCR LDR Human blood (dried blood
spots, nucleopore mem-
branes and ICT sample
pads), mosquitoes
1 mf/50 µL dried blood
diluted in 12 negative
blood spots
Blood: PR 24·3% (microscopy
17·1%; ICT 53·4%)
Mosquitoes: PR 31%
(PCR 22%)
Rao et al. (2006a);
Plichart and
Lemoine (2013)
W. bancrofti qPCR SspI Mosquitoes 1 L3 larva/mosquito SE 100%, SP 100% [experi-
mental infections]
Lulitanond et al.
(2004)
W. bancrofti,
P. falciparum
Multiplex
qPCR
LDR, 18S rDNA
(Plasmodium)
Pooled mosquitoes (∼8/pool) 0·1 pg gDNA PR: W. bancrofti 31·8%,
P. falciparum 19·2%, P. vivax
14·8%
Rao et al. (2009))
B. malayi qPCR HhaI Human blood 0·1–100 fg gDNA PR 66·6% (microscopy 63·1%) Rao et al. (2006b)
W. bancrofti, B. malayi Multiplex
qPCR
SspI, HhaI Mosquitoes (experimentally
infected)
1 L3/30 pooled mosqui-
toes (both species)
ND Intapan et al.
(2009)
W. bancrofti RT-qPCR Wb cut-1·2 Mosquitoes (experimentally
infected)
One infected mosquito/30
pooled
ND Laney et al. (2010)
W. bancrofti LAMP Nuclear scaﬀold/matrix
attachment region
Human blood, mosquitoes
spiked with mf, ﬁeld-col-
lected mosquitoes
0·1 pg gDNA (1/10th mf);
1 mf mL−1 blood; 1 mf/
60 pooled mosquitoes
(=SspI PCR)
Individual mosquitoes PR
1·8% pooled mosquitoes PR
0·31%
Takagi et al.
(2011); Kouassi
et al. (2015)
B. malayi, B. timori LAMP HhaI Cat blood 0·5–1 pg gDNA (1/200th-
1/100th mf) (=Hha I
PCR); 1 mf/40 µL blood
ND Poole et al. (2012)
O. volvulus qPCR O-150 Skin snips 10 fg gDNA µL−1
(1 pg PCR)
PR: qPCR 56·9% (PCR 33·9%;
skin snip microscopy 26%;
nodule palpation 37·9%)
Lloyd et al. (2015)
O. volvulus LAMP O-150 Skin snips 0·1 pg gDNA PR: 65·7% (PCR F3/R3 37·1%,
microscopy 31·4%)
Alhassan et al.
(2016)
O. volvulus LAMP OvGST1a Black ﬂies spiked with para-
site DNA
0·01 ng gDNA (1/10th
mf) (=OvGST1a PCR
F3/R3); 1 mf/200
pooled ﬂies
ND Alhassan et al.
(2014)
Soil-transmitted helminthes
A. lumbricoides,
A. duodenale,
N. americanus,
S. stercoralis
Multiplex
qPCR
ITS1,2 Human feces 10–103 copies Ascaris: PR 0·03% (0·04) Basuni et al.
(2011)18S rDNA Hookworms: PR 0·18% (0·01)
Strongyloides: PR 0·19% (0·03)
(KK coproscopy)
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Table 3. (Cont.)
Parasite species Assay type Target gene(s) Sample type(s)
Detection limit
(comparison assay)
Performance on clinical or ﬁeld
samples (comparison assays, if
any) [gold standard test, if any] Reference(s)
A. lumbricoides,
A. duodenale,
N. americanus,
S. stercoralis,
T. trichiura
qPCR ITS1,2 SSU rDNA Human feces 0·001 fg gDNA µL−1 Ascaris: PR 7% (5·5) Mejia et al. (2013)
Hookworms: PR 0·5% (0)
Strongyloides: PR 0·7% (0)
Trichuris: PR 3% (0·7) (direct
coproscopy)
A. lumbricoides,
T. trichiura and 17
other enteropathogens
Multiplex
qPCR
ITS1 SSU rDNA Human feces 106 copies g−1 feces SE 100%, SP 98·7%
[coproscopy]
Liu et al. (2013)
A. lumbricoides,
A. duodenale,
N. americanus,
S. stercoralis,
T. trichiura
Multiplex
qPCR
Species-speciﬁc,
non-coding, high
copy-number repeat
sequences
Human feces 2 fg gDNA µL−1 Ascaris: PR 59·4% (50·6) Pilotte et al.
(2016b)Necator: PR 75·9% (60·7)
Trichuris: PR 22·8% (17·7)
(multiplex qPCR)
S. stercoralis LAMP 28S rDNA Human feces <10 copies; 10−2/10−1
larvae /250 µL feces
SE 100%, SP 100% [copro-
scopy and real-time PCR]
Watts et al. (2014)
N. americanus LAMP ITS2 Human feces 0·4 fg gDNA SE 97%, SP 100% [KK
coproscopy]
Mugambi et al.
(2015)
Schistosomes
S. haematobium,
S. mansoni
Multiplex
qPCR
Cox1 Human stools 100 fg gDNA (both
species)
S. haematobium: PR 55% (0%) ten Hove et al.
(2008)S. mansoni: PR 73% (80%)
(duplicate KK)
S. haematobium,
S. mansoni
Singleplex
qPCR
IGS Snails 0·05 pg gDNA
(haematobium)
S. haematobium: PR 79–82%
(82%)
Kane et al. (2013)
0·1–1 pg gDNA (mansoni) S. mansoni: PR 26·3–47·4%
(21%) (PCR)
S. haematobium LAMP IGS Human urine 100 fg gDNA (1–10 fg
spiked in urine)
SE 100%, SP 86·67% [urine
ﬁltration microscopy]
Gandasegui et al.
(2015)
S. haematobium RPA DraI Parasite DNA spiked with
urine
100 fg gDNA ND Rosser et al.
(2015)
S. haematobium,
S. mansoni
LAMP DraI Sm1-7 Snails 0·1 fg gDNA (10 fgPCR) ND Abbasi et al.
(2010);
Hamburger et al.
(2013)
S. mansoni LAMP Mitochondrial minisa-
tellite region
Mouse feces 1 fg gDNA ND Fernández-Soto
et al. (2014) 8
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Xenomonitoring will play a major role in the
‘endgame’ ﬁnal stages of elimination programmes
and post-MDA surveillance of LF, since it gives
proxy estimates of disease burden and existing po-
tential for transmission while also being less invasive
for the community (Okorie and de Souza, 2016).
Furthermore, a reduction in infection rates in
vectors oﬀers a valuable demonstration of interrup-
tion of transmission (Owusu et al. 2015). The detec-
tion of ﬁlarial DNA or RNA in mosquitoes has
several advantages over the traditional method of
dissections. For example, it is relatively faster since
it can be used on pooled mosquitoes and is less
reliant on labour intensive and highly skilled dissec-
tion methods; it is more sensitive and allows the
species-speciﬁc identiﬁcation of ﬁlarial worms
(Okorie and de Souza, 2016). During an entomo-
logical survey in American Samoa, the estimated in-
fection rate in pooled Aedes polynesiensis was 0·68%
compared with the overall 0·11% rate observed by
dissection of individual mosquitoes (Chambers
et al. 2009). Real-time qPCR has recently been
used for detection ofW. bancrofti in mosquito popu-
lations across the world, including Sri Lanka (Rao
et al. 2014), Samoa (Hapairai et al. 2015), Ghana
(Owusu et al. 2015) and Tanzania (Irish et al.
2015). Under the perspective of a programmatic
use in detection of ﬁlarial DNA from both blood
and mosquitoes as part of post-MDA surveillance
and veriﬁcation of LF elimination, the possibility
of applying the same molecular test to both sample
types could potentially constitute a cost and oper-
ational advantage since laboratories in developing
countries will be required to be proﬁcient in only
one assay.
Multiplex assays are also available, including the
simultaneous detection of both W. bancrofti and
B. malayi with a sensitivity of a single L3 larva of
either species in up to 30 pooled mosquitoes
(Intapan et al. 2009). Of note is the duplex qPCR
assay co-amplifying DNA from W. bancrofti and
two species of Plasmodium (Plasmodium falciparum
or P. vivax) in mosquito pools (Rao et al. 2009),
which also showed a better sensitivity compared to
the respective singleplex assays. This method has
yet to be tested for its applicability in diagnosing
ﬁlariasis and malaria coinfection in human blood,
but it may prove useful in determining infection
rates in mosquitoes from areas of ﬁlariasis and
malaria co-endemicity. The possibility of diagnosing
coinfections has been explored before using a liga-
tion detection reaction-ﬂuorescent microsphere
assay (LDR-FMA) multiplex PCR on blood
samples of 517 people from Papua New Guinea
(Mehlotra et al. 2010). The assay, capable of detect-
ing simultaneously W. bancrofti and four species of
Plasmodium, revealed a frequent co-occurrence of
bancroftian ﬁlariasis and any of the four malaria
parasites in 29% of samples.
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The ability to discriminate infective mosquitoes
(harbouring the L3 infective stage of the parasite
and thus contributing to transmission) from mos-
quitoes which, although having taken an infected
blood meal do not support the development of the
parasite and thus remain unable to infect the
human host, is essential to obtain more precise esti-
mates of actual disease transmission potential from
xenomonitoring data (Okorie and de Souza, 2016).
For this purpose, reverse transcriptase (RT) PCR
and qPCR assays have been developed for detection
of L3 larvae-speciﬁc RNA transcripts in mosquitoes
(Laney et al. 2008, 2010; Vasuki et al. 2008). The
assays showed a detection limit of a single L3 larva
in pools of up to 25 mosquitoes (Laney et al. 2008;
Vasuki et al. 2008) or one infected mosquito in a
group of 30 uninfected insects (Laney et al. 2010).
The qPCR assay forW. bancrofti has also been mul-
tiplexed to detect both one L3 larvae-speciﬁc tran-
script and one further transcript present in all
parasite stages (Laney et al. 2010) thus allowing sim-
ultaneous detection of infected and infective insects
in one reaction. Neither of the RT–PCR assays has
been tested to date on ﬁeld-collected mosquitoes
from entomological surveys.
In terms of isothermal diagnostic tools, only one
LAMP assay has been developed for bancroftian
ﬁlariasis (Takagi et al. 2011). Targeting a portion
of the parasite nuclear scaﬀold/matrix attachment
region, the method successfully ampliﬁed the
DNA extracted from a single W. bancrofti microﬁ-
laria spiked in one millilitre of human blood or in a
pool of 60 Culex mosquitoes. This LAMP assay
has recently been used in Ghana screening for
W. bancrofti infection in 112 individual Anopheles
and 3635 Culex mosquitoes (arranged in 184 pools,
with a range of 7–20 insects per pool) (Kouassi
et al. 2015). However, the very low number of posi-
tive mosquitoes (1·8%) and pools (0·31%) and the
absence of a reference test prevented suﬃcient evalu-
ation of the assay performance. Nevertheless, the
two single mosquitoes and seven out of 11 (64%) of
pools testing positive by LAMP, subsequently
tested negative by PCR.
A LAMP assay has also been developed for the de-
tection of B. malayi and B. timori, based on the
tandem repeat HhaI (Poole et al. 2012). The assay
showed the same limit of detection (corresponding
to approximately 1/100th of a microﬁlaria) as the ori-
ginal HhaI PCR assay (Lizotte et al. 1994) when pure
parasite genomic DNAwas used, but a lower limit (1/
200th of a microﬁlaria) was observed when diluted cat
blood was used as template due perhaps to dead para-
site DNA circulating in blood (Poole et al. 2012).
Despite the potential applications and the possibil-
ity of developing a less invasive testing, the ampliﬁca-
tion of ﬁlarial DNA from samples such as sputum or
urine has been attempted only in a few instances.
Using PCR assays targeting theW. bancrofti repeated
elements SspI and AccI, DNA of the parasite was
ampliﬁed from the sputum of 32 (94%) out of 34
patients with conﬁrmed bancroftian ﬁlariasis with a
detection limit of one infected sputum sample
mixed with 14 uninfected samples (Abbasi et al.
1999). In a latter study involving 304 people from
Kenya, the sputum SspI PCR detected the presence
of the parasite in more patients (42·8%) compared
with ICT (39·1%) and blood microscopy (22%)
(Kagai et al. 2008). Thus, taking ICT as ‘gold stand-
ard’, the calculated sensitivity and speciﬁcity for
sputum PCR was 97·5 and 92·4%, respectively. The
DNA of W. bancrofti has also been successfully
detected in urine from 39 people from Brazil using
the same PCR assay (Lucena et al. 1998) for an
overall detection rate of 48·7–59% (in the ﬁrst and
second urine samples collected in the morning,
respectively).
The possibility of detecting ﬁlarial DNA shed in
the insect excreta and/or feces as a form of passive
xenomonitoring tool (allowing then to bypass the
need for pooling and extracting large numbers of
mosquitoes) has been recently explored (Pilotte
et al. 2016a). In this study, the authors showed
that using the HhaI repeat qPCR assay the DNA
of B. malayi can be detected in the excreta/feces of
a single mosquito (fed with microﬁlaraemic blood)
in pooled excreta from up to 500 uninfected
insects. The same approach was also used to detect
the presence of DNA from the malaria parasite
Plasmodium vivax (Pilotte et al. 2016a). The high
throughput and level of adaptability of excreta/
feces collection and DNA testing to a variety of mos-
quito trapping systems makes this novel approach to
xenomonitoring of LF very attractive and worth in-
vestigating in the near future, bearing also in mind
its potential applicability for the surveillance of
other blood-borne and mosquito-borne pathogens
such as malaria or arboviruses.
Onchocerciasis
Molecular detection tools for Onchocerca volvulus
have largely been based on the PCR ampliﬁcation
of the parasite-speciﬁc O-150 tandem repeat from
skin snips, particularly in the assessment of skin
microﬁlarial load reduction following PC (Alhassan
et al. 2015), and also from individual and pooled
black ﬂies in the Americas (Rodríguez-Pérez et al.
1999). The O-150 PCR has been adapted into a
qPCR format, showing increased sensitivity of detec-
tion of infection in skin snips compared with either
microscopy (Fink et al. 2011; Lloyd et al. 2015) and
also nodule palpation (Lloyd et al. 2015). The
TaqMan assay developed allowed a semi-quantitative
estimation of the microﬁlarial load from skin snips in
only 30 min (Lloyd et al. 2015).
The applicability of the O-150 assay for onchocer-
ciasis xenomonitoring in Africa is partially hindered
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by the need for a DNA probe hybridization step to
distinguish O. volvulus from the often co-endemic
cattle parasite Onchocerca ochengi, which is transmit-
ted by the same vectors (Alhassan et al. 2015).
However, the recently developed TaqMan assay
did not cross-amplify DNA from O. ochengi
(Lloyd et al. 2015) and so its future evaluation for
the detection of O. volvulus in African black ﬂies
appears promising. The detection of Onchocerca
DNA in the urine of 38 people from an endemic
area in Cameroon has also been reported, but with
a signiﬁcantly lower sensitivity (14%) compared
with either skin snip PCR (90%) or serum antigen
detection (100%) (Vincent et al. 2000).
To date, only one LAMP assay has been devel-
oped for speciﬁc detection of O. volvulus DNA in
black ﬂies (Alhassan et al. 2014). The assay was
capable of amplifying an amount of DNA equivalent
to a single microﬁlaria spiked in a pool of up to 200
ﬂies, irrespective of whether puriﬁed DNA or
simply boiled ﬂies were used as template. In the
latter case using boiled ﬂies, a reduction in analytical
sensitivity was observed for PCR (one mf in 150
ﬂies) (Alhassan et al. 2014).
The applicability of LAMP to detect Onchocerca
microﬁlariae in skin snips has also been tested
using the O-150 tandem repeat as a target
(Alhassan et al. 2016). When applied to skin snips
from 70 individuals living in endemic areas of
Ghana, the LAMP assay showed a signiﬁcantly
higher sensitivity (67·5% prevalence) compared
with both PCR using the external LAMP primers
(37·1%) and microscopy (31·4%). Additionally, the
detection of ampliﬁed parasite DNA was accom-
plished visually using pH-sensitive dyes (Alhassan
et al. 2016). To date, the ampliﬁcation of L3
larvae-speciﬁc transcripts by RT–PCR for the detec-
tion of infective black ﬂies (as it has been for LF in
mosquitoes) has yet to be reported.
Soil-transmitted helminths (STHs)
Infection with the soil-transmitted helminths
Ascaris lumbricoides, the hookworms (Ancylostoma
duodenale, A. ceylanicum, Necator americanus),
Trichuris trichiura and Strongyloides stercoralis is
usually determined by ﬁnding the parasite eggs or
larvae in stools by microscopy or culture (for hook-
worms and Strongyloides). However, coproscopy
(either by concentrated or direct wet smear, egg
ﬂotation or Kato-Katz method) is relatively insensi-
tive and time consuming, being most suitable for
only moderate-to-heavy intensity egg loads, and
thus light infections may typically be missed.
Molecular and biochemical assays that may
conﬁrm the presence of fecally-diagnosed helminths
(STHs and schistosomes under our consideration in
this review) through detection of antigens or DNA
could therefore oﬀer greater sensitivity. It is of
course important to acknowledge detection limita-
tions, as is the case in microscopic detection of
eggs, when considering parasite antigens and DNA
in low parasite burdens. As host parasite numbers
fall, eggs become more diﬃcult to detect and so
DNA levels are reduced also. In the case of STHs,
antigens and DNA would be present in feces from
both eggs and the bodies of parasites themselves
(through excretion/secretion, regurgitation, slough-
ing oﬀ from cuticle turnover, etc.), whilst schisto-
some antigens and DNA in feces would largely
derive from eggs. Coproantigen detection methods
are currently not commercially available or adopted
for STHs or S. stercoralis diagnosis. Serological
assays to detect antibodies against exposure to para-
site antigens are also not available for STHs al-
though several have been demonstrated in use for
Strongyloides infections where the clinical import-
ance of this infection may require greater attention
[for recent reviews see (Buonfrate et al. 2015) and
(Krolewiecki et al. 2013)]. Since co-infection with
multiple STH species is common in endemic areas
and the intensity of infection (worm burden) is the
most important parameter to assess the eﬃcacy of
STH control programmes, the development,
testing and reﬁnement of multiplex and quantitative
molecular assays should be considered a priority for
these parasites.
In recent years a variety of PCR assays, both con-
ventional and real-time, have been developed for the
molecular detection of STHs in human stools
(Verweij and Stensvold, 2014). Singleplex qPCR
assays have been described and tested on the stools
of 400 asymptomatic children from Ecuador (Mejia
et al. 2013) and 99 people from Argentina (Cimino
et al. 2015). In both studies, qPCR detected add-
itional infections for all STHs, which were missed
by microscopy, and there was signiﬁcant correlation
between the egg counts of Ascaris, Trichuris and
hookworms in samples and concentration of parasite
DNA determined by qPCR. In the Ecuador study,
qPCR was also used to conﬁrm complete clearance
of Ascaris infection in a cohort of 125 children
treated with albendazole and ivermectin (Mejia
et al. 2013).
Multiplex PCR and qPCR assays have also been
described and applied successfully in epidemiologic-
al studies globally (Basuni et al. 2011; Taniuchi et al.
2011; Liu et al. 2013; Gordon et al. 2015; Llewellyn
et al. 2016). One particular assay (targeting Ascaris,
Ancylostoma, Necator and Strongyloides) showed an
overall sensitivity of detection eight times higher
than using a combination of three wet smears and
one Kato-Katz slide on 77 stool samples collected
in Malaysia (Basuni et al. 2011). In another study
on 680 stool samples from Timor-Leste and
Cambodia, the prevalence of Ascaris and hookworm
infections determined by multiplex PCR was re-
spectively 1·2 and 2·9 higher than by microscopy
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(Llewellyn et al. 2016). A multiplex PCR assay with
Luminex beads was developed for detection of
Ascaris, Ancylostoma, Necator, Strongyloides and
three intestinal protozoa, showing high sensitivity
(90–100%) and speciﬁcity (95–100%) on 319 stool
samples previously tested by multiplex qPCR
(Taniuchi et al. 2011). Two qPCR assays amplifying
Ascaris and Trichuris DNA have also been incorpo-
rated into a TAC allowing the simultaneous detec-
tion of other 17 other pathogens (including
amongst others rotavirus, Salmonella, Vibrio cho-
lerae, Entamoeba histolytica, Cryptosporidium and
Giardia) (Liu et al. 2013). In the Philippines, the
simultaneous detection in stool samples of the two
cestode parasites Taenia saginata and T. solium
alongside Ascaris and hookworms has also been suc-
cessful using a multiplex approach (Gordon et al.
2015). In all the above studies, qPCR showed an
increased capacity in detecting polyparasitism com-
pared with coproscopy.
In a study on 796 stool samples from Kenya,
qPCR was signiﬁcantly more sensitive than two
Kato-Katz slides from a single stool sample in
detecting Ascaris and hookworm infections (Easton
et al. 2016). Furthermore signiﬁcant correlation
was also shown between these egg counts by Kato-
Katz, the DNA concentration determined by
qPCR and the number of expelled Ascaris worms,
showing that qPCR can be a good predictor for
worm burden. The possibility of using multiplex
qPCR to monitor changes in STH infection preva-
lence and intensity over time and in particular fol-
lowing MDA should be considered a priority
(Easton et al. 2016). A recent study clearly showed
the importance of using novel technologies to
reﬁne and improve the diagnostic potential of multi-
plex qPCR as applied to STHs (Pilotte et al. 2016b),
where next generation sequencing data were used to
identify non-coding, high copy-number repeated
DNA sequences in Ascaris, Ancylostoma, Necator,
Strongyloides and Trichuris, which were then
included in a novel multiplex qPCR assay. When
compared with a previous pentaplex assay
(Llewellyn et al. 2016) using ﬁeld collected stool
samples, the new assay showed improved sensitivity
detecting consistently down to 2 femtograms (fg) of
parasite DNA (corresponding to a small fraction of
the estimated DNA content of a fertilized egg or
single L1 larva of the species considered) (Pilotte
et al. 2016b).
In contrast to qPCR the use of isothermal ampliﬁ-
cation methods for STH stool diagnosis has been
overlooked so far, with the exception of two
LAMP assays targeting S. stercoralis (Watts et al.
2014) and N. americanus (Mugambi et al. 2015), re-
spectively. The former assay, amplifying a region of
the S. stercoralis 28S ribosomal DNA sequence,
showed excellent performance (100% sensitivity
and speciﬁcity) when tested on 28 stool specimens
from patients with S. stercoralis infection
conﬁrmed by a combination of microscopy and
real-time PCR (Watts et al. 2014). The latter assay,
targeting the internal transcribed spacer region 2 of
the N. americanus ribosomal DNA region, was
used on 86 positive and 20 negative specimens
(conﬁrmed by Kato-Katz microscopy) detecting
the parasite DNA with a 97% sensitivity and 100%
speciﬁcity (Mugambi et al. 2015). The N. ameri-
canus ITS2 LAMP was not tested on DNA from
the other two hookworms infecting humans (A. duo-
denale and A. ceylanicum), so its applicability as a
general hookworm diagnostic tool from feces has
yet to be veriﬁed.
Schistosomiasis
Conventional and real-time PCR assays have been
developed for the detection of Schistosoma spp.
DNA in numerous types of clinical sample (feces,
urine, plasma, serum, vaginal lavages) over the
years, showing overall increased sensitivity of detec-
tion compared with either stool/urine microscopy or
serology and antigen detection (Verweij and
Stensvold, 2014). In only one case the ampliﬁcation
of diﬀerent schistosomes, speciﬁcally S. haemato-
bium and S. mansoni, has been attempted with a
multiplex qPCR approach (ten Hove et al. 2008),
using 176 stool samples collected over 2 weeks
from 88 people in Senegal. Although the method
failed to detect a small number of S. mansoni infec-
tions (conﬁrmed by duplicate Kato-Katz), the
DNA of S. haematobium was frequently detected in
stools in the absence of eggs from this species (in-
cluding people in which eggs were found in the
urine and also a few in which the urine was egg-nega-
tive) (ten Hove et al. 2008).
Few LAMP assays have been published for schis-
tosomal DNA detection in clinical samples. The ﬁrst
described assay was developed to target S. japonicum
DNA in human serum (Xu et al. 2010). The assay
was used on sera from 20 infected and 30 uninfected
patients diagnosed by Kato-Katz microscopy with
only one false negative detected by LAMP, which
otherwise displayed high sensitivity and speciﬁcity
(96·7 and 100%, respectively) compared to conven-
tional PCR. In a successive study using sera from
110 infected and 42 uninfected patients (Xu et al.
2015), the same LAMP assay had a diagnostic per-
formance (95·5% sensitivity and 100% speciﬁcity)
which surpassed both enzyme-linked immunosorb-
ent assay (ELISA) (84·6% sensitivity and 85·7% spe-
ciﬁcity) and the indirect haemagglutination assay
(91·8% sensitivity and 88·1% speciﬁcity). In the
same study, the LAMP assay also detected S. japoni-
cum DNA in 10 out of 60 (16·7%) serum samples
from people that tested negative by triplicate Kato-
Katz, ELISA and IHA. The minimum time
required to detect infection with the three methods
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was also assessed using experimentally infected
rabbits (Xu et al. 2015). While ELISA and IHA
were positive only at 5 and 4 weeks post-infection re-
spectively, LAMPwas positive already at three days.
The isothermal detection by LAMP of S. haemato-
bium DNA in human urine has also been described
(Gandasegui et al. 2015). With the ability to detect
as little as 1 fg of parasite DNA using just the heated
urine supernatant as template, the LAMP ampliﬁed
all 18 S. haematobium-conﬁrmed patient samples
tested and eight out of 53 (15%) specimens negative
for eggs by microscopy (Gandasegui et al. 2015).
The RPA method has also been tested for its po-
tential to diagnose urinary schistosomiasis using oli-
gochromatographic lateral ﬂow strips (Rosser et al.
2015). Although the sensitivity and speciﬁcity of
the method was not evaluated on patients’ samples,
the ampliﬁcation eﬃciency for parasite DNA was
tested adding variable volume percentages of crude
urine (from 1·25 to 10% of total reaction volume)
at two parasite DNA concentrations [100 fgs and
10 picograms (pg) L−1]. Signiﬁcant ampliﬁcation
was observed even in the presence of 10% of added
volume of crude urine where 10 pg of DNA was
used, but not at lower DNA concentrations
(Rosser et al. 2015). These preliminary results
suggest further optimization of this RPA assay
could provide a rapid diagnostic test requiring only
minimal processing of urine samples. To date, only
one LAMP assay is described for detection of
S. mansoni in stool samples, and is described being
tested using mice feces (Fernández-Soto et al.
2014). Providing a detection limit of 1 fg of parasite
DNA the LAMP diagnostic gave positive results in
mice at 1-week post-infection in comparison with
the 4 weeks required for ELISA and 6 weeks for
Kato-Katzmicroscopy (Fernández-Soto et al. 2014).
Xenomonitoring of schistosomes in the snail
intermediate host has been advocated as a key com-
ponent of monitoring and surveillance when em-
phasis shifts from disease control to elimination
(Rollinson et al. 2013). Molecular tools also allow
detection of prepatent infections in snails that do
not shed parasite cercariae (Stothard et al. 2014).
Furthermore, they also allow the precise identiﬁca-
tion of the infecting schistosome species which is
crucial in areas where the snails act also as intermedi-
ate hosts for other animal schistosomes (Abbasi et al.
2012). PCR and multiplex PCR methods are pub-
lished for schistosome DNA detection in snails,
with some allowing concomitant snail species iden-
tiﬁcation (Stothard et al. 2014). Particularly interest-
ing are two qPCR assays allowing detection of
S. haematobium and S. mansoni DNA from Bulinus
spp. and Biomphalaria spp. snails by either ﬂuores-
cence or oligochromatographic lateral ﬂow strips
(Kane et al. 2013). Both assays showed a comparable
or even higher sensitivity of detection of parasite
DNA than traditional PCR approaches.
Schistosome DNA detection in snail vectors by
LAMP has been attempted too. One assay was
capable of detecting DNA from either a single
S. japonicum miracidium or one infected snail added
to a pool of up to 100 uninfected snails (Kumagai
et al. 2010). The assay has also been tested alongside
a nested PCR assay using ﬁeld-collected snails
from diﬀerent sites to determine the prevalence of
S. japonicum (Tong et al. 2014). Overall in pools of
50 snails from each of the 28 sampled sites, parasite
DNA was detected in seven out of 28 sites (25%
prevalence) compared with only 4 (14·3% preva-
lence) detected by PCR. Two LAMP assays target-
ing S. haematobium and S. mansoni are also
published and were compared for detection in
snails (Abbasi et al. 2010). Both methods showed a
detection limit 10 times lower (at 1 fg) than the
standard PCR assays (at 10 fg). These two methods
have also been used to test individual ﬁeld-collected
snails in Kenya (Hamburger et al. 2013) where the
LAMP assay returned infection prevalence estimates
comparable with those obtained through PCR and
qPCR. Interestingly, authors reported the possibil-
ity of pre-mixing all reaction components and
stabilizing them with the addition of 17·5% sucrose
to attain prolonged storage at room temperature
(Hamburger et al. 2013).
Concluding remarks and future directions
It is clear that a series of obstacles in terms of costs,
agreement on methods/standards, interpretation and
strategic application of result data must be overcome
to pave the way for nucleic acid-based molecular
diagnostics to become valuable tools for the control
and elimination programmes of MDA-targeted hel-
minths in general (as summarized in Table 1, with
individual parasite-speciﬁc research priorities sum-
marized in Box 1). In general, besides technical
feasibility and laboratory capacity, the major issue
related to the large-scale and routine implementation
of molecular diagnostics is its cost-eﬀectiveness.
Robust assessment of cost-eﬀectiveness will require
careful consideration of several factors and may need
to be viewed on a case-by-case basis depending upon
the situation, stage and needs of the programmes,
and stakeholder requirements. Aside from costs asso-
ciatedwith equipment and reagents for sample extrac-
tion and ampliﬁcation, other factors to consider
include the time involved for the predicted number
of samples to be screened and the sampling frequency,
whether the samples are used to screen for multiple
pathogens and all costs associated with planning and
executing the sampling (supplies, transport, personnel
and training). Since these aspects couldbe overlooked,
applying both mathematical modelling and full cost-
analysis should be considered pivotal in generating
evidence about actual cost-eﬀectiveness of molecular
diagnostics and set against a numerical sampling
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framework to judge aﬀordabilitywhenused indiscrete
applications, for example, to certify elimination. We
propose that with a greater focus on laboratory cap-
acity building, cost-eﬀectiveness analysis, agreements
on standards in methods (including in particular the
formation of quality assessment schemes and the use
of quantiﬁed referencematerial) and their strategic ap-
plication, the full potential of current and future
nucleic acid-based molecular diagnostics for MDA-
targeted helminths could now realize the more rapid
situational assessment required in achieving press
timeframes stipulated in the WHO 2020 Roadmap.
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